JUAN TORRAS Departament de Ciencies Clíniques, Universitat de Barcelona BARCELONA
1 protocol

Josep Maria Aran Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, BARCELONA
2 protocols

Josep Maria Grinyo Department of Clinical Sciences. Bellvitge Campus. BARCELONA
1 protocol

Miguel Hueso
  • Faculty, Hospital Universitari Bellvitge, and Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet de Llobregat
Research focus
  • Molecular biology
  • Dialysis, Cardiovascular disease, Molecular Medicine, Nanotechnology, Machine Learning
  • 1 Author merit


PhD, Barcelona, 2006


1 Protocol published
In vivo CD40 Silencing by siRNA Infusion in Rodents and Evaluation by Kidney Immunostaining

The co-stimulatory molecule CD40 and its ligand CD40L play a key role in the regulation of immunological processes and are involved in the pathophysiology of autoimmune and inflammatory diseases. Inhibition of the CD40-CD40L axis is a promising

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.